Veteran owned small business Spartan Medical Inc revealed on Wednesday that it plans to introduce Altapure LLC's AP-4 High-level Disinfection-System (HLDS) across the US market in the fight against COVID-19.
This critically needed, AP-4 advanced-ultrasonic-technology ensures that all healthcare and long-term care facilities, schools, universities, cruise lines, among others, can provide the cleanest/safest environment to fellow Americans. Altapure's first fully integrated high-level disinfection system AP–4 Medical HLD System will eliminate all bacteria, spores and viruses in a treated space. The system is easily operated by one person and many facilities have one person running two to three machines at a time.
The AP–4 is a single mobile unit platform, containing a combined submicron aerosol output device and environmental air re-processor system with data feedback. The process's agent is organic, biodegradable, food safe and leaves zero residue. Its PAA agent is an EPA registered cold sterilant, bactericide, fungicide, virucide and sporicide. In short, there has not yet been a pathogen that can survive the disinfection cycle, making the implementation of this state-of-the-art solution paramount during COVID-19 and beyond.
In collaboration with NASA, Altapure has shown efficacy in the sterilization of PPE with the 'peracetic acid technology.
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions